IQVIA’s Q2 2026: A Two-Segment Momentum Play Elevates the Revenue Forecast

IQVIA Holdings Inc. (NYSE: IQV) delivered its second-quarter 2026 report with EPS in focus and a revenue forecast that moved higher. The company posted revenue of $4,368 million, up 8.7% year-over-year, and generated an EPS lineup that executives framed as a positive earnings surprise relative to expectations. On a GAAP basis, EPS was $1.53, while Adjusted Diluted EPS came in at $3.15, up 12.1% year over year. The narrative hinges on two operating engines and a refreshed outlook that signals sustained momentum into 2027.

Two segments, one strategic upgrade

IQVIA has moved to a two-segment model—Commercial Solutions and Research & Development Solutions (R&D Solutions)—following a January 1, 2026 organizational overhaul. In tandem with the shift, prior period segment figures have been recast to align with the new reporting structure. The leadership frames this as a structural lift designed to accelerate collaboration, efficiency, and growth—an approach the market tends to reward when it translates into differentiated growth by line of business.

Second-quarter results and operating highlights

In a statement, Ari Bousbib, IQVIA’s chairman and CEO, said the team “executed well and delivered outstanding results, exceeding the high-end of our expectations for revenue, Adjusted EBITDA and Adjusted Diluted EPS.” Within the quarter, Commercial Solutions revenue reached $1,793 million (up 8.6% reported, 8.4% constant currency), while R&D Solutions brought in $2,575 million (up 8.8% reported, 8.6% constant currency). Excluding reimbursed expenses, R&D Solutions still grew 6.7% on a reported basis.

The company highlighted net new bookings of $3.15 billion for R&D Solutions, a 19% year-over-year increase, yielding a book-to-bill ratio of 1.22x. As of June 30, 2026, R&D Solutions’ contracted backlog stood at $34.2 billion, with an expectation that roughly $9.2 billion of that backlog would convert to revenue in the next twelve months—an indicator of momentum that investors watch for sustainability of top-line growth.

Cash flow, profitability, and pace of growth

The quarter produced solid cash generation: operating cash flow of $558 million and free cash flow of $360 million. On the profitability front, GAAP Net Income was $256 million, while Adjusted EBITDA rose to $994 million. The Adjusted Net Income figure was $527 million, with Adjusted Diluted EPS of $3.15—an uptick of 12.1% year over year.

Guidance lift and what it means for the revenue forecast

IQVIA raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS, signaling confidence not only in the current quarter but in the trajectory for the balance of the year. The firm’s commentary suggests a continued acceleration of organic growth, aided by strength in analytics, patient solutions, and AI-enabled offerings across both segments.

What the numbers portend for peers and the sector

The Q2 print underscores demand strength for IQVIA’s two-pronged approach—prized data and decision-support in Commercial Solutions, paired with robust scale in R&D Solutions. For sector peers, the message is less about a sudden spike and more about the durability of demand for healthcare intelligence, real-world evidence, and AI-assisted services. A healthy book-to-bill, expanding backlog, and a clear path to backlog conversion over the next year could pressure competitors to demonstrate similar productivity gains from organizational changes, pricing discipline, and portfolio mix.

Analysts will likely weigh the EPS consensus against IQVIA’s outperformance versus the high end of expectations, and investors will look to the sustainability of the backlog conversion and the degree to which AI-enabled capabilities translate to higher-margin growth. In a market where the horizon is increasingly shaped by data-enabled decision-making, IQVIA’s quarter could be read as a bellwether for the services and information providers that sit at the intersection of life sciences and health care.

Bottom line

IQVIA’s Q2 2026 results illuminate a company executing with disciplined clarity: two segments, stronger demand signals, growing backlog, and a raised revenue forecast. The EPS figures—GAAP and adjusted—align with and, in the company’s framing, exceed expectations. As the year unfolds, the combination of double-digit momentum in certain service lines, a healthier mix of revenue drivers, and the AI-enabled capabilities in the mix will be the key variables for IQVIA and its sector peers.